Weight loss achieved through GLP-1 therapy contributes significantly to improved lipid profiles, as adipose tissue reduction typically correlates with favourable changes in cholesterol levels
GIP fosters better sugar processing
Acta Diabetol (2014) 51(3):4917
Abstract The gut microbiota, which includes Akkermansia muciniphila , is known to modulate energy metabolism, glucose tolerance, immune system maturation and function in humans 1,2,3,4
B.PopaD
Data are in line with results in randomised controlled trials and show the long-term stable benefit of once weekly semaglutide. In August, Novo Nordisk published the findings of its own five-year study on Wegovy, known as the Select trial